Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules.

Autor: Pye CR; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Hewitt WM; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Schwochert J; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Haddad TD; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Townsend CE; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Etienne L; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Lao Y; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States., Limberakis C; World Wide Medicinal Chemistry, Groton Laboratories, Pfizer Inc. , Groton, Connecticut 06340, United States., Furukawa A; Modality Research Laboratories, Daiichi Sankyo Co., Ltd. , 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan., Mathiowetz AM; World Wide Medicinal Chemistry, Cambridge Laboratories, Pfizer Inc. , Cambridge, Massachusetts 02139, United States., Price DA; World Wide Medicinal Chemistry, Cambridge Laboratories, Pfizer Inc. , Cambridge, Massachusetts 02139, United States., Liras S; World Wide Medicinal Chemistry, Cambridge Laboratories, Pfizer Inc. , Cambridge, Massachusetts 02139, United States., Lokey RS; Department of Chemistry and Biochemistry, University of California , Santa Cruz, California 95064, United States.
Jazyk: angličtina
Zdroj: Journal of medicinal chemistry [J Med Chem] 2017 Mar 09; Vol. 60 (5), pp. 1665-1672. Date of Electronic Publication: 2017 Jan 25.
DOI: 10.1021/acs.jmedchem.6b01483
Abstrakt: Macrocyclic peptides are considered large enough to inhibit "undruggable" targets, but the design of passively cell-permeable molecules in this space remains a challenge due to the poorly understood role of molecular size on passive membrane permeability. Using split-pool combinatorial synthesis, we constructed a library of cyclic, per-N-methlyated peptides spanning a wide range of calculated lipohilicities (0 < AlogP < 8) and molecular weights (∼800 Da < MW < ∼1200 Da). Analysis by the parallel artificial membrane permeability assay revealed a steep drop-off in apparent passive permeability with increasing size in stark disagreement with current permeation models. This observation, corroborated by a set of natural products, helps define criteria for achieving permeability in larger molecular size regimes and suggests an operational cutoff, beyond which passive permeability is constrained by a sharply increasing penalty on membrane permeation.
Databáze: MEDLINE